# Certain Ophthalmic Products: Policy Regarding Compliance With 21 CFR Part 4; Guidance for Industry; Availability
> **Food and Drug Administration** · Notification of availability. · Published 2022-03-23 · 87 FR 16391
## Document
- **Document number:** 2022-05776
- **Category:** other
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 87 FR 16391
- **CFR reference:** 21 CFR 4
- **Publication date:** 2022-03-23
- **HHS docket:** Docket No. FDA-2022-D-0192
## Abstract

The Food and Drug Administration (FDA, Agency, or we) is announcing the availability of a final guidance for industry entitled "Certain Ophthalmic Products: Policy Regarding Compliance With 21 CFR part 4." This guidance describes FDA's compliance policy with respect to the requirements of FDA regulations that are now applicable to ophthalmic drugs that are packaged with eye cups, eye droppers, and other dispensers intended for ophthalmic use.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2022/03/23/2022-05776/certain-ophthalmic-products-policy-regarding-compliance-with-21-cfr-part-4-guidance-for-industry)
---
*AI Analytics · CC0 1.0*